Hem › Blodcancer › District of Columbia › Washington
Kliniska studier för Blodcancer i Washington, DC
19 studier för Blodcancer söker deltagare vid platser i och runt Washington (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekryterarFas 1
- MedStar Georgetown University Hospital, Washington D.C.
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi bort
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
RekryterarFas 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
RekryterarObservationsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekryterarObservationsstudieFriska volontärer välkomna
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi bort
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
RekryterarFas 1/2Friska volontärer välkomna
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RekryterarFas 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7 mi bort
Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
RekryterarFas 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
RekryterarFas 1/2Friska volontärer välkomna
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Longitudinal Studies of Patient With FPDMM
RekryterarObservationsstudieFriska volontärer välkomna
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
RekryterarFas 1/2Friska volontärer välkomna
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
RekryterarObservationsstudie
- The Center for Cancer and Blood Disorders, Bethesda · 7 mi bort
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
RekryterarFas 1
- Childrens National Medical Center, Washington D.C.
Mosaic Trial for Stem Cell Transplant Recipients
Rekryterar
- Georgetown University School of Medicine, Washington D.C.
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekryterarObservationsstudie
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · 7 mi bort
- Nih/Nhlbi, Bethesda · 7 mi bort
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
RekryterarFas 1/2
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · 7 mi bort
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
RekryterarFas 1/2Friska volontärer välkomna
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
RekryterarObservationsstudie
- George Washington University, Washington D.C.
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
RekryterarObservationsstudieFriska volontärer välkomna
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RekryterarFas 1
- Children's National Medical Center, Washington D.C.
- National Cancer Institute, Pediatric Oncology Branch, Bethesda · 7 mi bort
Blodcancer-studier i andra städer
- Houston, TX46 studier
- New York City, NY26 studier
- Boston, MA25 studier
- Seattle, WA18 studier
- Baltimore, MD18 studier
- Los Angeles, CA17 studier
- Durham, NC16 studier
- Chicago, IL15 studier
- Philadelphia, PA14 studier
- Edison, NJ13 studier
- Columbus, OH13 studier
- Nashville, TN13 studier
Andra studier i Washington
- Cancer (alla typer)58 studier
- Icke-småcellig lungcancer55 studier
- Bröstcancer46 studier
- Metastaserande cancer43 studier
- Lungcancer41 studier
- Prostatacancer38 studier
- Övervikt33 studier
- Kolorektal cancer29 studier
- Hjärt-kärlsjukdom28 studier
- Blåscancer26 studier
- Akut myeloid leukemi24 studier
- Äggstockscancer23 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.